INDUSTRY NEWS
China Absorbent Hygiene Products Expo,China Feminine Care Products Exрo- 2025-09
11
C&S Paper Co., Ltd. achieved double growth in both operating revenue and profit in the first half of 2025
C&S Paper Co., Ltd. achieved double growth in both operating revenue and profit in the first half of 2025 China C&S Paper Co., Ltd. achieved an operating revenue of approximately 4.330 billion yuan in the first half of 2025, representing a year-on-year increase of 7.67%. The net profit attributable to shareholders of the listed company was about 150 million yuan, up by 71.44% compared with the same period of the previous year. The basic earnings per share (EPS) stood at 0.12 yuan per share, a year-on-year growth of 71.43%. - 2025-09
11
Fujian Hengan Group Co., Ltd. achieved an operating revenue of 11.808 billion yuan in the first half of 2025
Fujian Hengan Group Co., Ltd. achieved an operating revenue of 11.808 billion yuan in the first half of 2025 Fujian Hengan Group Co., Ltd. achieved an operating revenue of approximately 11.808 billion yuan in the first half of 2025, remaining basically flat compared with the same period last year. The net profit attributable to shareholders of the listed company was about 1.373 billion yuan, a decrease of 2.6% compared with the same period of the previous year. - 2025-09
04
China OK Science and Technology Co., Ltd. forecasts RMB 358 million to 398 million revenue for the first half of 2025
China OK Science and Technology Co., Ltd. forecasts RMB 358 million to 398 million revenue for the first half of 2025 On 11 July, OK Science and Technology Co., Ltd. issued a preliminary financial projection for the first half of 2025: revenue is expected to reach RMB 358 million to 398 million, up 67.42 %–86.02 % year-on-year; net profit attributable to the parent company is anticipated at RMB 68.0069 million to 72.6915 million, up 93.83 %–108.47 % year-on-year; and basic earnings per share are projected at RMB 0.7285–0.7787 per share. - 2025-09
04
China C&S expects strong performance in the first half of 2025, with projected net profit attributable to shareholders from 1.4 billion yuan to 1.6 billion yuan
China C&S expects strong performance in the first half of 2025, with projected net profit attributable to shareholders from 1.4 billion yuan to 1.6 billion yuan On 11 July, C&S Paper Co., Ltd. announced that it expects net profit attributable to shareholders of the listed company for the first half of 2025 to reach RMB 140 million to 160 million, up 59.85 % to 82.68 % year on year. After excluding non-recurring gains and losses, net profit is forecast at RMB 135 million to 155 million, an increase of 95.95 % to 124.98 %. Basic earnings per share are projected at RMB 0.09 to 0.13. - 2025-07
22
China OK reported operating revenue of 199 million yuan in the first quarter of 2025
China OK reported operating revenue of 199 million yuan in the first quarter of 2025 In the first quarter of 2025, OK Science and Technology Co., Ltd. achieved an operating revenue of approximately 199 million yuan, an increase of 58.90% compared to the same period of the previous year. Its net profit attributable to the shareholders of the listed company reached about 40.5336 million yuan, up by 25.61% year-on-year. The basic earnings per share were 0.6079 yuan/share, an increase of 25.63% year-on-year. - 2025-07
22
China C&S reported operating revenue of 2.07 billion yuan in the first quarter of 2025
China C&S reported operating revenue of 2.07 billion yuan in the first quarter of 2025 In the first quarter of 2025, C&S Paper Co., Ltd. achieved an operating revenue of approximately 2.068 billion yuan, a year-on-year increase of 12.06%. Its net profit attributable to the shareholders of the listed company was about 66.7649 million yuan, a year-on-year decrease of 30.05%. The basic earnings per share were 0.05 yuan/share, representing a year-on-year decline of 28.57%. - 2025-07
22
China Jieya reported operating revenue of 124 million yuan in the first quarter of 2025
China Jieya reported operating revenue of 124 million yuan in the first quarter of 2025 In the first quarter of 2025, Tongling Jieya Biotechnology Co., Ltd. reported operating revenue of about 124 million yuan, a 4.62% year-on-year decrease. Its net profit attributable to shareholders was approximately 10.0627 million yuan, down by 27.61% year-on-year. The basic earnings per share were 0.13 yuan/share, representing a 23.53% year-on-year decline.
电话：010-64778188 
Email：cidpex@cnppri.com
公众微信号